publication venue for Dihydroartemisinin inhibits Epstein-Barr virus reactivation and replication targeting lytic proteins: insights for drug repurposing.. -. 2026 Next-generation sequencing for cytomegalovirus antiviral resistance genotyping in a clinical virology laboratory.. -. 2021
